| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |